Co-Authors
This is a "connection" page, showing publications co-authored by Sophie Susen and Yves Gruel.
Connection Strength
0.610
-
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring. Crit Care. 2020 06 19; 24(1):364.
Score: 0.222
-
Reply to the authors of "Age-adjusted D-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients". Anaesth Crit Care Pain Med. 2021 10; 40(5):100940.
Score: 0.060
-
Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR). Anaesth Crit Care Pain Med. 2021 08; 40(4):100919.
Score: 0.060
-
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 07; 203:163-171.
Score: 0.059
-
Anticoagulation in COVID-19: not strong for too long? Anaesth Crit Care Pain Med. 2021 04; 40(2):100857.
Score: 0.059
-
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia. Chest. 2021 06; 159(6):2417-2427.
Score: 0.058
-
Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR). Anaesth Crit Care Pain Med. 2018 Aug; 37(4):379-389.
Score: 0.047
-
Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study. Thromb Res. 2017 Oct; 158:126-133.
Score: 0.046